Cargando…

Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians

BACKGROUND: Before Pre-Exposure Prophylaxis (PrEP) was officially recommended and made available, a few surveys among gay and bisexual men, and persons living with HIV/AIDS (PLWHA), identified an informal use of antiretrovirals (ARVs) for PrEP among HIV-negative individuals. Before PrEP availability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palummieri, Antonio, De Carli, Gabriella, Rosenthal, Éric, Cacoub, Patrice, Mussini, Cristina, Puro, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704632/ https://www.ncbi.nlm.nih.gov/pubmed/29179700 http://dx.doi.org/10.1186/s12879-017-2819-5

Ejemplares similares

Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
por: Puro, Vincenzo, et al.
Publicado: (2013)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

Comfort Discussing HIV Pre-Exposure Prophylaxis with Patients Among Physicians in an Urban Emergency Department
por: Tortelli, Brett, et al.
Publicado: (2017)

Awareness and use of HIV pre-exposure prophylaxis and factors associated with awareness among MSM in Beijing, China
por: Sun, Yanming, et al.
Publicado: (2023)

Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017
por: Powis, Kathleen M., et al.
Publicado: (2019)

1552. HIV Pre-Exposure Prophylaxis Awareness, Uptake, and Persistence Among People at Risk for HIV in Two Communities in Western Kenya
por: Romo, Matthew L, et al.
Publicado: (2023)

Awareness and use of nonoccupational HIV post-exposure prophylaxis and factors associated with awareness among MSM in Beijing, China
por: Sun, Yanming, et al.
Publicado: (2021)

Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis
por: Chaowanachan, Thanyanan, et al.
Publicado: (2013)

HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy
por: Mammone, Alessia, et al.
Publicado: (2012)

Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
por: Streed, Carl G., et al.
Publicado: (2022)

Prevalence of renal and bone risk factors among individuals prescribed oral pre-exposure prophylaxis for HIV
por: Fields, Sheldon D., et al.
Publicado: (2023)

2088. Real-World Geographic Variations of HIV Diagnosis Rates among Individuals Prescribed and not Prescribed Oral HIV Pre-Exposure Prophylaxis (PrEP) Regimens in the United States
por: Tao, Li, et al.
Publicado: (2022)

Nevirapine, Sodium Concentration and HIV-1 RNA in Breast Milk and Plasma among HIV-Infected Women Receiving Short-Course Antiretroviral Prophylaxis
por: Salado-Rasmussen, Kirsten, et al.
Publicado: (2015)

Perspectives of women prescribed HIV pre-exposure prophylaxis (PrEP)
por: Park, Connie, et al.
Publicado: (2017)

2560. Assessing Resident Perspectives on Prescribing Pre-Exposure Prophylaxis for HIV
por: Shallal, Anita, et al.
Publicado: (2019)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Antiretroviral prophylaxis to prevent post-natal transmission of HIV through breastfeeding
por: Kuhn, Louise
Publicado: (2008)

HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons — United States, 2019
por: Rao, Shubha, et al.
Publicado: (2021)

Recent HIV infection among newly diagnosed with HIV cases in Turin, Italy
por: Raimondo, Mariangela, et al.
Publicado: (2010)

Service outcome of antiretroviral Post-Exposure Prophylaxis (PEP) for occupational HIV exposure among health care personnel
por: Shah, Asha, et al.
Publicado: (2010)

Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention
por: Morton, Jennifer F., et al.
Publicado: (2017)

Accuracy of self‐report of HIV viral load among people with HIV on antiretroviral treatment
por: Sewell, J, et al.
Publicado: (2016)

Adherence to Antiretroviral Therapy Among People Living with HIV
por: Achappa, Basavaprabhu, et al.
Publicado: (2013)

Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation
por: Ross, Ian, et al.
Publicado: (2017)

Exploring the Shift From HIV Pre-exposure Prophylaxis Awareness to Uptake Among Young Gay and Bisexual Men
por: Koester, Kimberly A., et al.
Publicado: (2021)

Adoption of HIV pre-exposure prophylaxis among women at high risk of HIV infection in Kenya
por: Bien-Gund, Cedric H., et al.
Publicado: (2022)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
por: Duwal, Sulav, et al.
Publicado: (2019)

Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
por: Mandal, Subhra, et al.
Publicado: (2017)

Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients
por: Bañó, Maria, et al.
Publicado: (2020)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023)

Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2018)

Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy
por: Cheng, Chien-Yu, et al.
Publicado: (2010)

Awareness of and Willingness to Use Oral Pre-Exposure Prophylaxis for HIV Prevention among HIV-Serodiscordant Heterosexual Couples: A Cross-Sectional Survey in Xinjiang, China
por: Mijiti, Peierdun, et al.
Publicado: (2013)

Reducing Delays to Antiretroviral (ARV) Receipt in Children Prescribed Post-Exposure Prophylaxis (PEP) for HIV: Meds-in-Hand and a Multidisciplinary Team Approach
por: Epstein, Rachel, et al.
Publicado: (2017)

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy
por: Saracino, Annalisa, et al.
Publicado: (2018)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000
por: Vandenhende, Marie-Anne, et al.
Publicado: (2015)

The Italian PrEPventHIV challenge: a scoping systematic review on HIV pre-exposure prophylaxis monitoring in Italy
por: Ferrara, Pietro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b815r13av8lk8klc1mtgu8hm0m